BRIEF-Humacyte Q4 Operating Income USD -28.088 Million Vs. IBES Estimate USD -29.9 Million

Reuters
28 Mar
BRIEF-Humacyte Q4 Operating Income USD -28.088 Million Vs. IBES Estimate USD -29.9 Million

Mar 28 (Reuters) - Humacyte Q4 operating expenses USD 28.088 million.

  • Q4 basic EPS USD -0.16
  • Q4 net income USD -20.94 million vs. IBES estimate USD -31.3 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10